
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
Takaki Asano, Bertrand Boisson, Fanny Onodi, et al.
Science Immunology (2021) Vol. 6, Iss. 62
Open Access | Times Cited: 354
Takaki Asano, Bertrand Boisson, Fanny Onodi, et al.
Science Immunology (2021) Vol. 6, Iss. 62
Open Access | Times Cited: 354
Showing 26-50 of 354 citing articles:
Persistent serum protein signatures define an inflammatory subcategory of long COVID
Aarthi Talla, Suhas Vasaikar, Gregory L. Szeto, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Aarthi Talla, Suhas Vasaikar, Gregory L. Szeto, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78
Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 71
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 71
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Jérémie Rosain, Anna‐Lena Neehus, Jérémy Manry, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 621-645.e33
Open Access | Times Cited: 65
Jérémie Rosain, Anna‐Lena Neehus, Jérémy Manry, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 621-645.e33
Open Access | Times Cited: 65
The conneXion between sex and immune responses
Katherine S. Forsyth, Nikhil Jiwrajka, Claudia D. Lovell, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 7, pp. 487-502
Open Access | Times Cited: 65
Katherine S. Forsyth, Nikhil Jiwrajka, Claudia D. Lovell, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 7, pp. 487-502
Open Access | Times Cited: 65
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 28
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 28
Altered X-chromosome inactivation predisposes to autoimmunity
Christophe Huret, Léa Férrayé, Antoine David, et al.
Science Advances (2024) Vol. 10, Iss. 18
Open Access | Times Cited: 27
Christophe Huret, Léa Férrayé, Antoine David, et al.
Science Advances (2024) Vol. 10, Iss. 18
Open Access | Times Cited: 27
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus
C. David, Carlos A. Arango-Franco, Mihaly Badonyi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 8
Open Access | Times Cited: 19
C. David, Carlos A. Arango-Franco, Mihaly Badonyi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 8
Open Access | Times Cited: 19
Human life within a narrow range: The lethal ups and downs of type I interferons
Yanick J. Crow, Jean‐Laurent Casanova
Science Immunology (2024) Vol. 9, Iss. 97
Closed Access | Times Cited: 19
Yanick J. Crow, Jean‐Laurent Casanova
Science Immunology (2024) Vol. 9, Iss. 97
Closed Access | Times Cited: 19
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 18
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 18
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease
C. David, Mihaly Badonyi, Robin Kechiche, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 2
Open Access | Times Cited: 17
C. David, Mihaly Badonyi, Robin Kechiche, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 2
Open Access | Times Cited: 17
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Angélique Chauvineau‐Grenier, Paul Bastard, Antoine Servajean, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 459-470
Open Access | Times Cited: 66
Angélique Chauvineau‐Grenier, Paul Bastard, Antoine Servajean, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 459-470
Open Access | Times Cited: 66
Nonresolving inflammation redux
Carl Nathan
Immunity (2022) Vol. 55, Iss. 4, pp. 592-605
Open Access | Times Cited: 65
Carl Nathan
Immunity (2022) Vol. 55, Iss. 4, pp. 592-605
Open Access | Times Cited: 65
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E. Vazquez, Jamin Liu, et al.
Science Immunology (2022) Vol. 8, Iss. 90
Open Access | Times Cited: 62
Paul Bastard, Sara E. Vazquez, Jamin Liu, et al.
Science Immunology (2022) Vol. 8, Iss. 90
Open Access | Times Cited: 62
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
Alexis Mathian, Paul Breillat, Karim Dorgham, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1695-1703
Open Access | Times Cited: 61
Alexis Mathian, Paul Breillat, Karim Dorgham, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1695-1703
Open Access | Times Cited: 61
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Paôline Laurent, Chao Yang, André F. Rendeiro, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 61
Paôline Laurent, Chao Yang, André F. Rendeiro, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 61
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19
Caspar I. van der Made, Mihai G. Netea, Frank L. van der Veerdonk, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Caspar I. van der Made, Mihai G. Netea, Frank L. van der Veerdonk, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 59
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Evangelos Andreakos, Laurent Abel, Donald C. Vinh, et al.
Nature Immunology (2021) Vol. 23, Iss. 2, pp. 159-164
Open Access | Times Cited: 57
Evangelos Andreakos, Laurent Abel, Donald C. Vinh, et al.
Nature Immunology (2021) Vol. 23, Iss. 2, pp. 159-164
Open Access | Times Cited: 57
Novel genes and sex differences in COVID-19 severity
Raquel Cruz, Silvia Diz‐de Almeida, Miguel López de Heredia, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 22, pp. 3789-3806
Open Access | Times Cited: 57
Raquel Cruz, Silvia Diz‐de Almeida, Miguel López de Heredia, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 22, pp. 3789-3806
Open Access | Times Cited: 57